Adults with anomalous aortic origin of a coronary artery: impact of invasive functional testing on clinical decision making-insights from the MuSCAT registry

成人冠状动脉主动脉起源异常:侵入性功能检查对临床决策的影响——来自 MuSCAT 注册研究的启示

阅读:2

Abstract

AIMS: In line with the contemporary European Society of Cardiology and American Heart Association/American College of Cardiology guidelines, the work-up for anomalous aortic origin of a coronary artery (AAOCA) should include anatomical and functional evaluation. OBJECTIVE: This study aims to evaluate the impact of invasive functional testing vs. real-world non-invasive functional testing on the management strategy for adults with potentially malignant AAOCA. METHODS AND RESULTS: In this multicentre prospective study, all AAOCA patients, ≥16 years, with an interarterial or intraseptal course underwent diagnostic work-up, including anatomic and non-invasive functional evaluation. Invasive functional testing followed the MuSCAT protocol with fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR)/resting full-cycle ratio (RFR), and intravascular ultrasound (IVUS) at baseline and during pharmacological stress. Seventy-six patients [53% female, median age 53 (44-59) years] were included. Sixteen (21%) initially presented with cardiac chest pain. High-risk anatomy, e.g. acute take-off angle <30°, was present in 75 (99%) patients. Non-invasive functional testing was positive in 10 (13%), negative in 59 (78%) and inconclusive in 2 (3%). Invasive functional testing showed discrepant results compared with non-invasive testing in 21 (28%) patients. In 15 (20% of the overall cohort) patients, the treatment recommendation was altered based on the invasive functional testing results. CONCLUSION: This study in adult AAOCA patients revealed a 28% discrepancy between non-invasive and invasive functional testing, altering management recommendations for 20% of the overall cohort. Implementing optimal functional testing modalities may enhance risk stratification for ischaemic events and sudden cardiac death, enabling tailored treatment strategies for AAOCA patients. Further prospective research with long-term follow-up is needed to evaluate clinical outcomes.Registered in the Dutch Trial Register #NL8777; https://onderzoekmetmensen.nl/en.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。